Siemens Healthineers AG Stock News

Siemens Healthineers CEO Bernd Montag discusses the healthcare company's first-quarter earnings and the impact of the omicron variant on the company's revenues.

Siemens Healthineers (SMMNY) launched its Enhanced Liver Fibrosis ((ELF)) test in the U.S.Currently, the ELF test is exclusively available through collaborations with Labcorp (LH)

Several analysts have recently updated their ratings and price targets for Siemens Healthineers (ETR: SHL): 12/23/2021 Siemens Healthineers was given a new 65.00 ($73.03) price target on by analysts at Kepler Capital Markets. 12/22/2021 Siemens Healthineers was given a new 60.00 ($67.42) price target on by analysts at Nord/LB. 12/17/2021 Siemens Healthineers []

Kepler Capital Markets set a 65.00 ($73.03) price objective on Siemens Healthineers (ETR:SHL) in a research note published on Thursday morning, Borsen Zeitung reports. Other analysts also recently issued research reports about the company. UBS Group set a 59.00 ($66.29) price objective on Siemens Healthineers in a research note on Wednesday, November 17th. Credit Suisse []

Siemens Healthineers (ETR:SHL) has been assigned a 60.00 ($67.42) target price by equities research analysts at Nord/LB in a research note issued to investors on Wednesday, Borsen Zeitung reports. Nord/LBs price target suggests a potential downside of 8.62% from the stocks previous close. Several other equities research analysts also recently commented on the stock. Kepler []

Siemens Healthineers (ETR:SHL) has been given a 60.00 ($67.42) price objective by equities research analysts at Nord/LB in a research note issued on Wednesday, Borsen Zeitung reports. Nord/LBs target price would suggest a potential downside of 4.94% from the stocks current price. A number of other brokerages have also recently commented on SHL. Deutsche Bank []

The global Closed MRI Systems market was valued at 3092.5 Million USD in 2020 and will grow with a CAGR of 2.76% from 2021 to 2027. The growing elderly population and public awareness of the benefits of MRI scanning are

The global Refurbished Medical Devices market was valued at 1128.45 Million USD in 2020 and will grow with a CAGR of 10.07% from 2021 to 2027. Hospital budget cuts, a large inventory of used or old medical devices, rising demand

Dec , 2021 (Market intelligence data) The Interstitial Lung Disease (ILD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global

New York, Dec. 17, 2021 (GLOBE NEWSWIRE) -- According to the new market research report " Radiotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiotherapy/Radiopharmaceuticals), Product (External Beam Radiotherapy Products, Internal Radiotherapy Products, Radiotherapy Software, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), and End User (Hospitals, Radiation Therapy Centers, and Specialty Clinics), and Geography", published by The Insight Partners , the global radiotherapy market was valued at US$ 6,474.78 million in 2020 and it is projected to reach US$ 10,170.80 million by 2028; it is expected to grow at a CAGR of 5.9% from 2021 to 2028. Get Exclusive Sample Pages of Radiotherapy Market Size - COVID-19 Impact and Global Analysis with Strategic Insights: https://www.theinsightpartners.com/sample/TIPMD00002668/ Radiotherapy Market: Competition Landscape and Key Developments Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries, Ltd., Elekta AB, Hitachi, Ltd., Koninklijke Philips N.V., Brainlab AG, PROTOM INTERNATIONAL, Varian Medical Systems, Inc., Maastro, and Mevion Medical Systems are among the key companies operating in the radiotherapy market.

The Alfred E. Mann Foundation for Scientific Research (AMF) today confirmed the appointment of two new senior executives. Los Angeles-based AMF appointed Charles Nelson as its new COO and Corey Dishmon as its chief legal officer/chief business officer. Nelson joins AMF from Alcon, where he oversaw the manufacturing science and technology organization. He is a [] The post Alfred E. Mann Foundation brings former Alcon, Siemens Healthineers execs into C-suite appeared first on Drug Delivery Business .

The Cytomegalovirus (CMV) Diagnostic research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Cytomegalovirus (CMV) Diagnostic research report offers information

The partnership could impact millions of MRI exams worldwide in a substantial AI partnership in healthcare Subtle Medical, a key provider of artificial intelligence (AI) solutions for medical imaging, and Siemens Healthineers, a leading medical technology company, announced a partnership to integrate Subtle Medicals SubtleMR image-enhancement software into the MRI machines of Siemens Healthineers. SubtleMR [] The post Subtle Medical To Become The First Partner Siemens Healthineers Welcomes On Board Their New Open Recon Interface appeared first on AiThority .

MENLO PARK, Calif., Nov. 26, 2021 /PRNewswire/ -- Subtle Medical, a key provider of artificial intelligence (AI) solutions for medical imaging, and Siemens Healthineers, a leading medical technology company, announced today a partnership to integrate Subtle Medical''s SubtleMR

Positron Emission Tomography (PET) scanners are commonly combined with computed tomography X-ray for the treatment of many disorders. PET systems are categorized as full ring PET systems or partial ring PET systems based on their operational and geometrical abilities. A